의료진프로필

Comprehensive Young Age Breast Cancer registry from clinical, genomics, and patient-reported outcomes measured with 15 years follow-up: the CHARM cohort profile

Kang, DB; Park, S; Kim, HJ; Lee, JS; Han, JY; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Kim, JY; Nam, SJ; Cho, JH; Park, YH

Social support during re-entry period and long-term quality of life in breast cancer survivors: a 10-year longitudinal cohort study

Cho, H; Kang, DB; Shin, DW; Kim, N; Lee, SK; Lee, JE; Nam, SJ; Cho, J

Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants

Kim, N; Cho, WK; Park, W; Lee, JE; Nam, SJ; Kim, SW; Yu, JH; Chae, BJ; Lee, SK; Ryu, JM; Ko, ES; Kim, H

Impact of Social Support during Diagnosis and Treatment on Disease Progression in Young Patients with Breast Cancer: A Prospective Cohort Study

Kang, D; Park, S; Kim, HJ; Kim, SW; Lee, JE; Yu, J; Lee, SK; Kim, JY; Nam, SJ; Cho, J; Park, YH

Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/ pertuzumab for HER2-positive breast cancer

Kim, N; Kim, JY; Park, W; Cho, WK; Kim, TG; Im, YH; Ahn, JS; Lee, JE; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Park, YH; Kim, H

A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Jung, HH; Kim, JY; Cho, EY; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH

The Impact of HER2-Low Expression on Oncologic Outcomes in Hormone Receptor-Positive Breast Cancer

Park, WK; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Ryu, JM; Chae, BJ

The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis

Kim, K; Park, W; Kim, H; Cho, WK; Kim, N; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM

Risk factors of breast cancer recurrence in pathologic complete response achieved by patients following neoadjuvant chemotherapy: a single-center retrospective study

Choi, JY; Woen, D; Jang, SY; Lee, H; Shin, DS; Kwak, Y; Lee, H; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM

Comprehensive Clinical Characterization of Decade-Long Survivors of Metastatic Breast Cancer

Shin, J; Kim, JY; Oh, JM; Lee, JE; Kim, SW; Nam, SJ; Park, W; Park, YH; Ahn, JS; Im, YH

Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy

Choi, HJ; Lee, JH; Jung, CS; Ryu, JM; Chae, BJ; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE; Jung, YJ; Kim, HY

Pretreatment endocrine symptoms and recurrence-free survival among young premenopausal patients with breast cancer: a prospective cohort study

Kang, DB; Cho, JH; Park, S; Kim, HJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Kim, JY; Nam, SJ; Park, YH

Prediction Model for Postoperative Quality of Life Among Breast Cancer Survivors Along the Survivorship Trajectory From Pretreatment to 5 Years: Machine Learning-Based Analysis

Kang, D; Kim, H; Cho, J; Kim, Z; Chung, M; Lee, JE; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Ryu, JM; Lee, SK

Trends of axillary surgery in breast cancer patients with axillary lymph node metastasis: a comprehensive single-center retrospective study

Kim, YJ; Kim, HJ; Chung, SY; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM

Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer

Kim, JY; Park, S; Cho, EY; Lee, JE; Jung, HH; Chae, BJ; Kim, SW; Nam, SJ; Cho, SY; Park, YH; Ahn, JS; Lee, S; Im, YH

Progesterone Receptor Expression Level Predicts Prognosis of Estrogen Receptor-Positive/HER2-Negative Young Breast Cancer: A Single-Center Prospective Cohort Study

Kwak, Y; Jang, SY; Choi, JY; Lee, H; Shin, DS; Park, YH; Kim, JY; Ahn, JS; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM

Diagnostic Value of FDG PET/CT in Surveillance after Curative Resection of Breast Cancer

Lee, H; Choi, JY; Park, YH; Lee, JE; Kim, SW; Nam, SJ; Cho, YS

Prognostic Impact of Elevation of Cancer Antigen 15-3 (CA15-3) in Patients With Early Breast Cancer With Normal Serum CA15-3 Level

Ryu, JM; Kang, DB; Cho, JH; Lee, JE; Kim, SW; Nam, SJ; Lee, SK; Kim, YJ; Im, YH; Ahn, JS; Park, YH; Kim, JY; Lee, HYJ; Kang, MR; Yu, JH

Effectiveness of Self-Assessment, TAilored Information, and Lifestyle Management for Cancer Patients? Returning to Work (START): A Multi-center, Randomized Controlled Trial

Kang, DB; Bae, KR; Ahn, Y; Kim, N; Nam, SJ; Lee, JE; Lee, SK; Shim, YM; Sinn, DH; Oh, SY; Chun, M; Heo, J; Cho, JH

Clinical Characteristics and Prognosis of Metaplastic Breast Cancer Compared with Invasive Ductal Carcinoma: A Propensity-Matched Analysis

Lee, JH; Ryu, JM; Lee, SK; Chae, BJ; Lee, JE; Kim, SW; Nam, SJ; Yu, J

Suppression of Platelet-Derived Growth Factor Receptor-Alpha Overcomes Resistance to Trastuzumab through STAT3-Dependent IL-6 Reduction in HER2-Positive Breast Cancer Cells

Kim, S; Kim, H; Jeong, Y; You, D; Yoon, SY; Lo, EJ; Nam, SJ; Lee, JE; Kim, SW

The use of absorbable skin stapler in mastectomy does not increase the rate of surgical site infection

Lee, J; Lee, JE; Ryu, JM; Kim, SW; Nam, SJ; Yu, JH

The efficacy and safety of an indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: A multicenter, randomized, open-label, parallel phase 3 clinical trial

Bang, YJ; Choi, HJ; Kim, I; Lee, MH; Lee, SY; Shin, HJ; Nam, SJ; Lee, JE; Chae, BJ; Lee, SK; Ryu, JM; Kim, SW

Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay

Lee, JH; Ryu, JM; Ahn, JH; Cho, SY; Lee, SK; Yu, J; Chae, BJ; Nam, SJ; Han, J; Lee, JE; Kim, SW

Omission of chemotherapy for hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer: patterns of treatment and outcomes from the Korean Breast Cancer Society Registry

Kangleon-Tan, HL; Sim, J; Yoo, JY; Lee, ES; Lee, H; Yang, SM; Seong, MK; Park, EH; Nam, SJ; Park, MH; Lee, S; Park, WC; Kangleon, RG; Dy, CB; Bae, SY; Jung, SP

Survival benefit from axillary surgery in patients aged 70 years or older with clinically node-negative breast cancer: A population-based propensity-score matched analysis

Cha, C; Jeong, J; Kim, HK; Nam, SJ; Seong, MK; Woo, J; Park, WC; Ryu, S; Chung, MS; Korean Breast Canc Soc

Suggestion for the omission of post-mastectomy chest wall radiation therapy in patients who underwent skin-sparing/ nipple-sparing mastectomy

Kim, N; Park, W; Cho, WK; Kim, HY; Choi, DH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Chae, BJ; Lee, SK; Ryu, JM; Mun, GH; Pyon, JK; Jeon, BJ

Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?

Choi, HJ; Ryu, JM; Lee, JH; Bang, Y; Oh, J; Chae, BJ; Nam, SJ; Kim, SW; Lee, JE; Lee, SK; Yu, J

Real World Evidence of Neoadjuvant Docetaxel/Carboplatin/Trastuzumab/ Pertuzumab (TCHP) in Patients with HER2-Positive Early or Locally Advanced Breast Cancer: A Single-Institutional Clinical Experience

Kim, JY; Nam, SJ; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Ahn, JS; Im, YH; Kim, SW; Park, YH

Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort

Jo, H; Park, S; Kim, HR; Kim, H; Hong, J; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Oh, SY; Choi, SJ; Kim, JY; Ahn, JS; Im, YH; Nam, EM; Nam, SJ; Park, YH

Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of In Situ Carcinoma

Lee, JH; Lee, H; Bang, YJ; Ryu, JM; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ

Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients

Bang, YJ; Kwon, WK; Nam, SJ; Kim, SW; Chae, BJ; Lee, SK; Ryu, JM; Kim, JW; Yu, J; Lee, JE

Validation of Korean Version of the COmprehensive Score for Financial Toxicity (COST) among Breast Cancer Survivors

Shim, S; Kang, D; Kim, N; Han, G; Lim, J; Kim, H; Park, J; Lee, M; Lee, JE; Kim, SW; Yu, J; Chae, BJ; Ryu, JM; Nam, SJ; Lee, SK; Cho, J

Improved Prediction of Survival Outcomes Using Residual Cancer Burden in Combination With Ki-67 in Breast Cancer Patients Underwent Neoadjuvant Chemotherapy

Kim, JY; Oh, JM; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Kim, K; Im, YH

Primary Angiosarcoma of the Breast: A Single-Center Retrospective Study in Korea

Kim, YJ; Ryu, JM; Lee, SK; Chae, BJ; Kim, SW; Nam, SJ; Yu, JH; Lee, JE

Relationship Between Breast and Axillary Pathologic Complete Response According to Clinical Nodal Stage: A Nationwide Study From Korean Breast Cancer Society

Ryu, JM; Choi, HJ; Park, EH; Kim, JY; Lee, YJ; Park, S; Lee, J; Park, HK; Nam, SJ; Kim, SW; Lee, JH; Lee, JE

Histologic analysis according to HER2 gene status in HER2 2+invasive breast cancer: a study of 280 cases comparing ASCO/CAP 2013 and 2018 guideline recommendations

Hwang, HW; Hong, SA; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Cho, SY; Cho, EY

Immediate breast reconstruction has no impact on the oncologic outcomes of patients treated with post-mastectomy radiation therapy: a comparative analysis based on propensity score matching

Kim, N; Kim, H; Park, W; Choi, DH; Cho, WK; Nam, SJ; Lee, JE; Kim, SW; Yu, J; Lee, SK; Jeon, BJ; Pyon, JK; Mun, GH; Kim, TG

Elevated Level of Nerve Growth Factor (NGF) in Serum-Derived Exosomes Predicts Poor Survival in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy

Jung, HH; Kim, JY; Cho, EY; Oh, JM; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH

Is Sentinel Lymph Node Biopsy for Breast Cancer with Cytology-Proven Axillary Metastasis Safe? A Prospective Single-Arm Study

Choi, HJ; Ryu, JM; Chae, BJ; Nam, SJ; Yu, J; Lee, SK; Lee, JE; Kim, SW

Prevalence, treatment patterns, and prognosis of low estrogen receptor-positive (1% to 10%) breast cancer: a single institution's experience in Korea

Park, YH; Karantza, V; Calhoun, SR; Park, S; Lee, S; Kim, JY; Yu, JH; Kim, SW; Lee, JE; Nam, SJ; Aktan, G; Marsico, M

Axillary Lymph Node Dissection Rates and Prognosis From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer

Gwark, S; Noh, WC; Ahn, SH; Lee, ES; Jung, Y; Kim, LS; Han, W; Nam, SJ; Gong, G; Kim, SO; Kim, HJ

Effect of Poloxamer-Based Thermo- Sensitive Sol-Gel Agent on Upper Limb Dysfunction after Axillary Lymph Node Dissection: A Double-Blind Randomized Clinical Trial

Choi, HJ; Ryu, JM; Chae, BJ; Kim, EK; Min, JW; Shin, HJ; Nam, SJ; Yu, J; Lee, JE; Lee, SK; Kim, SW

Effect of mind and body education on quality of life among young breast cancer patients: a randomized controlled trial

Kang, D; Lee, JK; Kim, N; Kim, S; Lee, SK; Lee, JE; Nam, SJ; Cho, J

Association between cancer stigma and job loss among cancer survivors

Shim, S; Kang, D; Bae, KR; Lee, WY; Nam, SJ; Sohn, TS; Jeong, BC; Sinn, DH; Kweon, SS; Shim, YM; Cho, J

Preoperative diagnosis of BRCA1/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients

Woo, J; Gwak, G; Park, I; Bae, BN; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM

Changes in Korean National Healthcare Insurance Policy and Breast Cancer Surgery Trend in Korea

Rayzah, M; Ryu, JM; Lee, JH; Nam, SJ; Kim, SW; Lee, SK; Yu, J; Lee, KT; Bang, SI; Mun, GH; Pyon, JK; Jeon, BJ; Lee, JE

Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer

Gwark, S; Ahn, SH; Noh, WC; Lee, ES; Jung, Y; Kim, LS; Han, W; Nam, SJ; Gong, G; Kim, SO; Kim, HJ

Prediction of pathologic complete response to neoadjuvant chemotherapy using machine learning models in patients with breast cancer

Kim, JY; Jeon, E; Kwon, S; Jung, H; Joo, S; Park, Y; Lee, SK; Lee, JE; Nam, SJ; Cho, EY; Park, YH; Ahn, JS; Im, YH

Validation of the Clinical Treatment Score Post-Five Years in Breast Cancer Patients for Predicting Late Distant Recurrence: A Single-Center Investigation in Korea

Lee¹, JH; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM

Entelon(R) (Vitis vinifera Seed Extract) Prevents Cancer Metastasis via the Downregulation of Interleukin-1 Alpha in Triple-Negative Breast Cancer Cells

You¹, D; Jeong, Y; Yoon, SY; Kim, SA; Lo, E; Kim, SW; Lee, JE; Nam, SJ; Kim, S

Celastrol attenuates the inflammatory response by inhibiting IL-1 beta expression in triple-negative breast cancer cells

You¹, D; Jeong, Y; Yoon, SY; Kim, SA; Kim, SW; Nam, SJ; Lee, JE; Kim, S

Deep Learning-Based Prediction Model for Breast Cancer Recurrence Using Adjuvant Breast Cancer Cohort in Tertiary Cancer Center Registry

Kim¹, JY; Lee, YS; Yu, J; Park, Y; Lee, SK; Lee, M; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Kang, M; Im, YH

Clinical Outcomes Following Letrozole Treatment according to Estrogen Receptor Expression in Postmenopausal Women: LETTER Study (KBCSG-006)

Ahn¹, SG; Nam, SJ; Ahn, SH; Jung, YS; Park, HK; Lee, SJ; Kang, SS; Han, WS; Park, KH; Park, YL; Lee, J; Youn, HJ; Kim, JH; Yoo, Y; Song, JY; Ko, BK; Gwak, G; Chung, MS; Kim, SY; Cho, SH; Kim, D; Chang, MC; Moon, BI; Kim, LS; Kim, SJ; Park, MH; Kim, TH; Cho, J; Lim, CW; Bae, YT; Gong, G; Bae, YK; Lee, A; Jeong, J

The efficacy and safety of indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: a multi-center open-label parallel phase-2 clinical trial

Kim¹, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Lee, JE; Nam, SJ; Shin, HJ; Kim, SW

Relation Between Tumor Size and Lymph Node Metastasis According to Subtypes of Breast Cancer

Min¹, SK; Lee, SK; Woo, J; Jung, SM; Ryu, JM; Yu, J; Lee, JE; Kim, SW; Chae, BJ; Nam, SJ

Validation of the GenesWell BCT Score in Young Asian Women With HR+/HER2-Early Breast Cancer

Kwon¹, MJ; Ryu, JM; Cho, SY; Nam, SJ; Kim, SW; Lee, J; Lee, SJ; Park, JY; Park, HY; Hong, S; Kim, K; Han, J; Moon, Y; Shin, YK; Lee, JE

Breast radiologic complete response is associated with favorable survival outcomes after neoadjuvant chemotherapy in breast cancer

Woo¹, J; Ryu, JM; Jung, SM; Choi, HJ; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ

Does chemotherapy or radiotherapy affect the postoperative complication in breast cancer patients who underwent immediate breast reconstruction with tissue expander?

Jung¹, SM; Jeon, BJ; Woo, J; Ryu, JM; Lee, SK; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Pyon, JK; Mun, GH; Bang, SI; Lee, JE

Survival of Breast-Conserving Surgery Plus Radiotherapy versus Total Mastectomy in Early Breast Cancer

Kim¹, H; Lee, SB; Nam, SJ; Lee, ES; Park, BW; Park, HY; Lee, HJ; Kim, J; Chung, Y; Kim, HJ; Ko, BS; Lee, JW; Son, BH; Ahn, SH

Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome

Park¹, YH; Lal, S; Lee, JE; Choi, YL; Wen, J; Ram, S; Ding, Y; Lee, SH; Powell, E; Lee, SK; Yu, JH; Ching, KA; Nam, JY; Kim, SW; Nam, SJ; Kim, JY; Cho, SY; Park, S; Kim, J; Hwang, S; Kim, YJ; Bonato, V; Fernandez, D; Deng, S; Wang, S; Shin, H; Kang, ES; Park, WY; Rejto, PA; Bienkowska, J; Kan, Z

Association of the Implant Surface Texture Used in Reconstruction With Breast Cancer Recurrence

Lee¹, KT; Kim, S; Jeon, BJ; Pyon, JK; Mun, GH; Ryu, JM; Lee, SK; Yu, J; Kim, SW; Lee, JE; Nam, SJ; Bang, SI

Response of Triple-negative Breast Cancer Liver Metastasis to Oral Recombinant Methioninase in a Patient-derived Orthotopic Xenograft (PDOX) Model

Lim¹, HI; Yamamoto, J; Han, QH; Sun, YU; Nishino, H; Tashiro, Y; Sugisawa, N; Tan, YY; Choi, HJ; Nam, SJ; Bouvet, M; Hoffman, RM

WNT5A augments cell invasiveness by inducing CXCL8 in HER2-positive breast cancer cells

Kim¹, S; You, D; Jeong, Y; Yoon, SY; Kim, SA; Kim, SW; Nam, SJ; Lee, JE

Is the intraoperative frozen section analysis of sentinel lymph nodes necessary in clinically negative node breast cancer?

Jung¹, SM; Woo, J; Ryu, JM; Lee, SK; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Kim, EJ; Lee, JE

Distribution of tumor subtypes in bilateral breast cancer Comparison between synchronous and metachronous cancer

Kim¹, H; Lee, H; Choi, DH; Park, W; Cho, WK; Nam, SJ; Lee, JE; Kim, SW; Lee, SK; Cho, EY; Cho, SY

Impact of Serum Lipid on Breast Cancer Recurrence

Jung¹, SM; Kang, D; Guallar, E; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Cho, J; Lee, SK

Dynamic and subtype-specific interactions between tumour burden and prognosis in breast cancer

Lee¹, SB; Kim, HK; Choi, Y; Ju, YW; Lee, HB; Han, W; Noh, DY; Son, BH; Ahn, SH; Kim, KS; Nam, SJ; Kim, EK; Park, HY; Park, WC; Lee, JW; Moon, HG

Oral Methioninase Inhibits Recurrence in a PDOX Mouse Model of Aggressive Triple-negative Breast Cancer

Lim¹, HI; Hamada, K; Yamamoto, J; Han, QH; Tan, YY; Choi, HJ; Nam, SJ; Bouvet, M; Hoffman, RM

Clinical Characteristics and Exploratory Genomic Analyses of Germline BRCA1 or BRCA2 Mutations in Breast Cancer

Park¹, S; Lee, E; Park, S; Lee, S; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Kim, JY; Ahn, JS; Im, YH; Park, WY; Park, K; Park, YH

Prognostication of a 13-immune-related-gene signature in patients with early triple-negative breast cancer

Kim¹, JY; Jung, HH; Sohn, I; Woo, SY; Cho, H; Cho, EY; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH

Influence of complications following total mastectomy and immediate reconstruction on breast cancer recurrence

Lee¹, KT; Jung, JH; Mun, GH; Pyon, JK; Bang, SI; Lee, JE; Nam, SJ

Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with oestrogen receptor-positive and HER2-negative, lymph node-positive breast cancer

Kim¹, HJ; Noh, WC; Lee, ES; Jung, YS; Kim, LS; Han, W; Nam, SJ; Gong, GY; Kim, HJ; Ahn, SH

Surgical impact on anxiety of patients with breast cancer: 12-month follow-up prospective longitudinal study

Kim¹, J; Cho, J; Lee, SK; Choi, EK; Kim, IR; Lee, JE; Kim, SW; Nam, SJ

A Single Low Dose of Eribulin Regressed a Highly Aggressive Triple-negative Breast Cancer in a Patient-derived Orthotopic Xenograft Model

Lim¹, HI; Yamamoto, J; Inubushi, S; Nishino, H; Tashiro, Y; Sugisawa, N; Han, QH; Sun, Y; Choi, HJ; Nam, SJ; Kim, MB; Lee, JS; Hozumi, C; Bouvet, M; Singh, SR; Hoffman, RM

Aberrant Lymphatic Drainage in the Contralateral Axilla in Patients with Isolated Ipsilateral Breast Tumor Recurrence

Ryu¹, JM; Chae, BJ; Lee, JE; Yu, J; Nam, SJ; Kim, SW; Lee, SK

Influence of complications following total mastectomy and immediate reconstruction on breast cancer recurrence

Lee¹, KT; Jung, JH; Mun, GH; Pyon, JK; Bang, SI; Lee, JE; Nam, SJ

Efficacy of health coaching and a web-based program on physical activity, weight, and distress management among cancer survivors: A multi-centered randomised controlled trial

Yun¹, YH; Lim, CI; Lee, ES; Kim, YT; Shin, KH; Kim, YW; Park, KJ; Jeong, SY; Ryu, KW; Han, W; Jung, KH; Park, SC; Kim, MS; Kim, S; Shim, YM; Oh, JH; Lee, JM; Ryoo, SB; Woo, J; Noh, DY; Park, JW; Moon, BI; Kim, HJ; Nam, SJ; Lee, DH; Zo, JI; Park, SM; Kang, E; Rhee, Y; Jung, JY; Sim, JA; Lee, J; Shin, A

Prognosis of BRCA1/2-negative breast cancer patients with HBOC risk factors compared with sporadic breast cancer patients without HBOC risk factors

Ryu¹, JM; Nam, SJ; Kim, SW; Lee, JE; Chae, BJ; Lee, SK; Yu, J

Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial

Kim¹, HA; Lee, JW; Nam, SJ; Park, BW; Im, SA; Lee, ES; Jung, YS; Yoon, JH; Kang, SS; Lee, SJ; Park, KH; Jeong, J; Cho, SH; Kim, SY; Kim, LS; Moon, BI; Lee, MH; Kim, TH; Park, C; Jung, SH; Gwak, G; Kim, J; Kang, SH; Jin, YW; Kim, HJ; Han, SH; Han, W; Hur, MH; Noh, WC

Oncologic Outcomes of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Patients with Tumor-Nipple Distance Less than 2.0 cm

Alsharif¹, E; Ryu, JM; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Lee, JE

Survival benefit of postoperative radiotherapy for ductal carcinoma in situ after breast-conserving surgery: a Korean population-based cohort study

Kim¹, BH; Ko, BK; Bae, JW; Nam, S; Park, MH; Jeong, J; Lee, HJ; Chang, JH; Kim, S; Hwang, KT

Prediction of axillary pathologic response with breast pathologic complete response after neoadjuvant chemotherapy

Choi¹, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, JE; Lee, SK

Retrospectively validating the results of the ACOSOG Z0011 trial in a large Asian Z0011-eligible cohort

Jung¹, J; Han, W; Lee, ES; Jung, SY; Han, JH; Noh, DY; Kim, Y; Choi, HJ; Lee, JE; Nam, SJ; Lee, JW; Kim, HJ; Um, E; Kim, JH; Park, S; Cho, YU

Nomogram for accurate prediction of breast and axillary pathologic response after neoadjuvant chemotherapy in node positive patients with breast cancer

Choi¹, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, JH; Lee, JE; Lee, SK

Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study

Kang¹, D; Kim, IR; Choi, EK; Im, YH; Park, YH; Ahn, JS; Lee, JE; Nam, SJ; Lee, HK; Park, JH; Lee, DY; Lacouture, ME; Guallar, E; Cho, J

TP53 upregulates -smooth muscle actin expression in tamoxifen-resistant breast cancer cells

Kim¹, S; You, D; Jeong, Y; Yu, J; Kim, SW; Nam, SJ; Lee, JE

A predictive model for high/low risk group according to oncotype DX recurrence score using machine learning

Kim¹, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE

Practical approaches to automated digital image analysis of Ki-67 labeling index in 997 breast carcinomas and causes of discordance with visual assessment

Kwon¹, AY; Park, HY; Hyeon, J; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Cho, SY; Cho, EY

A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients

Hwang¹, HW; Jung, H; Hyeon, J; Park, YH; Ahn, JS; Im, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Choi, M; Cho, SY; Cho, EY

Serum Trace Elements and Their Associations with Breast Cancer Subgroups in Korean Breast Cancer Patients

Choi¹, R; Kim, MJ; Sohn, I; Kim, S; Kim, I; Ryu, JM; Choi, HJ; Kim, JM; Lee, SK; Yu, J; Kim, SW; Nam, SJ; Lee, JE; Lee, SY

Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer?

Lee¹, SK; Kim, SW; Yu, JH; Lee, JE; Kim, JY; Woo, J; Lee, S; Kim, EK; Moon, HG; Ko, SS; Nam, SJ

The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans

Kim¹, H; Choi, DH; Park, W; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Jung, BY

Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea

Ryu¹, JM; Choi, HJ; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Choi, DH; Park, YH; Kim, JW; Seo, JS; Park, JH; Lee, JE; Kim, SW

Patterns of Axillary Lymph Node Metastasis in Breast Cancer: A Prospective Single-Center Study

Choi¹, HJ; Kum, JM; Ryu, JM; Kim, I; Nam, SJ; Yu, J; Lee, SK; Lee, JE; Kim, SW

Only estrogen receptor "positive" is not enough to predict the prognosis of breast cancer

Ryu¹, JM; Choi, HJ; Kim, I; Lee, SK; Yu, J; Kim, JE; Kang, B; Lee, JE; Nam, SJ; Kim, SW

PIK3CA Mutations and Neoadjuvant Therapy Outcome in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Sequential Analysis

Seo¹, Y; Park, YH; Ahn, JS; Im, YH; Nam, SJ; Cho, SY; Cho, EY

Prognostic value of immunohistochemically detected p53 in adjuvant chemotherapy-treated triple negative breast cancer

Bae¹, SY; Jung, SP; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ

Use of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients with Axillary Node-Positive Breast Cancer in Diagnosis

Choi¹, HJ; Kim, I; Alsharif, E; Park, S; Kim, JM; Ryu, JM; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE

Chronologically changing patterns in the survival of korean patients with breast cancer and related clinical factors: a nationwide registry-based study

Lee¹, SB; Ko, SS; Park, CH; Nam, SJ; Choi, JE; Jung, YS; Park, WC; Son, BH

Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer

Bae¹, SY; Nam, SJ; Jung, Y; Lee, SB; Park, BW; Lim, W; Jung, SH; Yang, HW; Jung, SP

Berberine down-regulates IL-8 expression through inhibition of the EGFR/ MEK/ERK pathway in triple-negative breast cancer cells

Kim¹, S; You, D; Jeong, Y; Yu, J; Kim, SW; Nam, SJ; Lee, JE

BCT score predicts chemotherapy benefit in Asian patients with hormone receptor- positive, HER2-negative, lymph node-negative breast cancer

Kwon¹, MJ; Lee, SB; Han, J; Lee, JE; Lee, JW; Gong, G; Beitsch, PD; Nem, SJ; Ahn, SH; Nam, BH; Shin, YK

Effect of Body Mass Index on Survival in Breast Cancer Patients According to Subtype, Metabolic Syndrome, and Treatment

Cho¹, WK; Choi, DH; Park, W; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY; Ahn, S

Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy

Kim¹, HJ; Lee, MH; Lee, JE; Park, S; Lee, ES; Kang, YJ; Shin, HN; Kim, SI; Lee, JH; Im, SA; Ahn, SH; Lee, KS; Sohn, J; Kim, S; Nam, SJ; Han, W

Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort

Kim¹, JY; Lim, JE; Jung, HH; Cho, SY; Cho, EY; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH

Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype

Bae¹, SY; Jung, SP; Jung, ES; Park, SM; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ

Preoperative Axillary US in Early-Stage Breast Cancer: Potential to Prevent Unnecessary Axillary Lymph Node Dissection

Kim¹, GR; Choi, JS; Han, BK; Lee, JE; Nam, SJ; Ko, EY; Ko, ES; Lee, SK

Verification of a Western Nomogram for Predicting Oncotype DX (TM) Recurrence Scores in Korean Patients with Breast Cancer

Kim¹, JM; Ryu, JM; Kim, I; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE

Which Patients with Left Breast Cancer Should be Candidates for Heart-Sparing Radiotherapy?

Cho¹, WK; Park, W; Choi, DH; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY

Prognostic Validation of the American Joint Committee on Cancer 8th Staging System in 24,014 Korean Patients with Breast Cancer

Kim¹, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE

Assessment of Quality of Life and Safety in Postmenopausal Breast Cancer Patients Receiving Letrozole as an Early Adjuvant Treatment

Jung¹, Y; Lee, SJ; Lee, J; Noh, WC; Nam, SJ; Park, BW; Bae, YT; Kang, SS; Parks, HK; Yoon, JH; Kim, JR; Cho, SH; Kim, LS; Moon, BI; Jung, SH; Lim, CW; Kim, SY; Park, HY; Song, J; Lee, KM; Park, SH; Jeong, J; Park, HL; Kim, SW; Kwak, BS; Kang, SH; Cho, YU; Gwak, GH; Park, YL; Kim, SW; Han, S

Genetic Diagnosis before Surgery has an Impact on Surgical Decision in BRCA Mutation Carriers with Breast Cancer

Park¹, S; Lee, JE; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Yu, J; Kim, SW; Nam, SJ

The effect of adjuvant chemotherapy on survival in Korean patients with node negative T1c, triple negative breast cancer

Lim¹, ST; Park, CH; Kim, SY; Nam, SJ; Kang, EY; Moon, BI; Lee, HJ; Jeon, YW; Gwak, H; Suh, YJ

Association between mammographic density and tumor marker-defined breast cancer subtypes: a case-control study

Shin¹, J; Lee, JE; Ko, HY; Nguyen, TL; Nam, SJ; Hopper, JL; Song, YM

Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures

Kan¹, ZY; Ding, Y; Kim, J; Jung, HH; Chung, W; Lal, S; Cho, S; Fernandez-Banet, J; Lee, SK; Kim, SW; Lee, JE; Choi, YL; Deng, S; Kim, JY; Ahn, JS; Sha, Y; Mu, XJ; Nam, JY; Im, YH; Lee, S; Park, WY; Nam, SJ; Park, YH

Breast Cancer Epidemiology of the Working-Age Female Population Reveals Significant Implications for the South Korean Economy

Park¹, JH; Lee, SK; Lee, JE; Kim, SW; Nam, SJ; Kim, JY; Ahn, JS; Park, W; Yu, J; Park, YH

Berberine Suppresses Fibronectin Expression through Inhibition of c-Jun Phosphorylation in Breast Cancer Cells

Jeong¹, Y; You, D; Kang, HG; Yu, J; Kim, SW; Nam, SJ; Lee, JE; Kim, S

Berberine Suppresses Cell Motility Through Downregulation of TGF-beta 1 in Triple Negative Breast Cancer Cells

Kim¹, S; Lee, J; You, D; Jeong, Y; Jeon, M; Yu, J; Kim, SW; Nam, SJ; Lee, JE

Development and validation of the smart management strategy for health assessment tool-short form (SAT-SF) in cancer survivors

Yun¹, YH; Jung, JY; Sim, JA; Lee, J; Noh, DY; Han, W; Park, KJ; Jeong, SY; Park, JW; Wu, HG; Chie, EK; Kim, HJ; Jung, KH; Zo, JI; Kim, S; Lee, JE; Nam, SJ; Lee, ES; Oh, JH; Kim, YW; Kim, YT; Shim, YM

Risk Factors Affecting Breast Cancer-related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by Taxane

Park¹, S; Lee, JE; Yu, J; Paik, HJ; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Kim, SW; Nam, SJ; Kim, EK; Kang, E; Yang, EJ

Genetic and Clinical Characteristics of Phyllodes Tumors of the Breast

Kim¹, JY; Yu, JH; Nam, SJ; Kim, SW; Lee, SK; Park, WY; Noh, DY; Nam, DH; Park, YH; Han, W; Lee, JE

A train the trainer program for healthcare professionals tasked with providing psychosocial support to breast cancer survivors

Park¹, E; Yoon, J; Choi, EK; Kim, IR; Kang, D; Lee, SK; Lee, JE; Nam, SJ; Ahn, JS; Visser, A; Cho, J

Different prognosis of young breast cancer patients in their 20s and 30s depending on subtype: a nationwide study from the Korean Breast Cancer Society

Ryu¹, JM; Yu, J; Kim, SI; Kim, KS; Moon, HG; Choi, JE; Jeong, J; Byun, KD; Nam, SJ; Lee, JE; Lee, SK; Kim, SW

Who are happy survivors? Physical, psychosocial, and spiritual factors associated with happiness of breast cancer survivors during the transition from cancer patient to survivor

Kang¹, D; Kim, IR; Choi, EK; Yoon, JH; Lee, SK; Lee, JE; Nam, SJ; Han, W; Noh, DY; Cho, J

Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy

Cho¹, N; Han, W; Han, BK; Bae, MS; Ko, ES; Nam, SJ; Chae, EY; Lee, J; Kim, SH; Kang, BJ; Song, BJ; Kim, EK; Moon, HJ; Il Kim, S; Kim, SM; Kang, E; Choi, Y; Kim, HH; Moon, WK

Variations in plasma concentrations of tamoxifen metabolites and the effects of genetic polymorphisms on tamoxifen metabolism in Korean patients with breast cancer

Woo¹, HI; Lee, SK; Kim, J; Kim, SW; Yu, J; Bae, SY; Lee, JE; Nam, SJ; Lee, SY

Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis

Ryu¹, JM; Lee, SK; Kim, JY; Yu, JH; Kim, SW; Lee, JE; Han, SH; Jung, YS; Nam, SJ

Circulating tumor DNA shows variable clonal response of breast cancer during neoadjuvant chemotherapy

Kim¹, JY; Park, D; Son, DS; Nam, SJ; Kim, SW; Jung, HH; Kim, YJ; Park, G; Park, WY; Lee, JE; Park, YH

Targeted exome sequencing of Korean triple-negative breast cancer reveals homozygous deletions associated with poor prognosis of adjuvant chemotherapy-treated patients

Jeong¹, HM; Kim, RN; Kwon, MJ; Oh, E; Han, J; Lee, SK; Choi, JS; Park, S; Nam, SJ; Gong, GY; Nam, JW; Choi, DH; Lee, H; Nam, BH; Choi, YL; Shin, YK

Development of a Nomogram to Predict N2 or N3 Stage in T1-2 Invasive Breast Cancer Patients with No Palpable Lymphadenopathy

Kim¹, I; Ryu, JM; Kim, JM; Choi, HJ; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ

Comparison of Core Needle Biopsy and Surgical Specimens in Determining Intrinsic Biological Subtypes of Breast Cancer with Immunohistochemistry

You¹, K; Park, S; Ryu, JM; Kim, I; Lee, SK; Yu, J; Kim, SW; Nam, SJ; Lee, JE

Clinical outcomes according to molecular subtypes in stage II-III breast cancer patients treated with neoadjuvant chemotherapy followed by surgery and radiotherapy

Kim¹, H; Park, W; Huh, SJ; Choi, DH; Noh, JM; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Cho, EY

Dimerization of EGFR and HER2 induces breast cancer cell motility through STAT1-dependent ACTA2 induction

Jeon¹, M; You, D; Bae, SY; Kim, SW; Nam, SJ; Kim, HH; Kim, S; Lee, JE

MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer

Han¹, J; Choi, YL; Kim, H; Choi, JY; Lee, SK; Lee, JE; Choi, JS; Park, S; Choi, JS; Kim, YD; Nam, SJ; Nam, BH; Kwon, MJ; Shin, YK

Fertility Rates in Young Korean Breast Cancer Patients Treated with Gonadotropin-Releasing Hormone and Chemotherapy

Kim I1¹, Ryu JM1, Paik HJ1, Park S1, Bae SY1, Lee SK1, Yu J1, Kim SW1, Nam SJ1, Lee JE1.

Basic Facts of Breast Cancer in Korea in 2014:The 10-Year Overall Survival Progress

Park EH1¹, Min SY2, Kim Z3, Yoon CS4, Jung KW5, Nam SJ6, Oh SJ7, Lee S8, Park BW9, Lim W10, Hur MH11; Korean Breast Cancer Society.

Oncologic Outcomes after Immediate Breast Reconstruction Following Total Mastectomy in Patients with Breast Cancer: A Matched Case-Control Study

Ryu JM1¹, Paik HJ1, Park S1, Yi HW1, Nam SJ1, Kim SW1, Lee SK1, Yu J1, Bae SY1, Lee JE1.

Effects of exercise intervention in breast cancer patients: is mobile health (mHealth) with pedometer more effective than conventional program using brochure?

Uhm KE1¹,2, Yoo JS3, Chung SH3, Lee JD4, Lee I4,5, Kim JI4, Lee SK6, Nam SJ6, Park YH7, Lee JY8, Hwang JH9.

Feasibility and Prognostic Effect of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Cytology-Proven, Node-Positive Breast Cancer

Park S1¹, Lee JE2, Paik HJ1, Ryu JM1, Bae SY1, Lee SK1, Kim SW1, Nam SJ1.

Tumor-associated macrophages (TAMs) and tumor-infiltrating lymphocytes (TILs) in pretherapeutic breast cancer core biopsies: Anti-tumoral effect of immune cells associated with neoadjuvant chemotherapy

Yoon N¹, Han KM, Cho SY, Kim SW, Lee JE, Nam SJ, Cho EY

Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer

Kim H1¹, Cho DY2, Choi DH3,4, Oh M2, Shin I2, Park W5, Huh SJ5, Nam SJ6, Lee JE6, Kim SW6.

Conditional disease-free survival among patients with breast cancer

Paik HJ1¹, Lee SK, Ryu JM, Park S, Kim I, Bae SY, Yu J, Lee JE, Kim SW, Nam SJ.

Goserelin plus tamoxifen compared to chemotherapy followed by tamoxifen in premenopausal patients with early stage-, lymph node-negative breast cancer of luminal A subtype

Alramadhan M1¹, Ryu JM1, Rayzah M1, Nam SJ1, Kim SW1, Yu J1, Lee SK1, Bae SY1, Park S1, Paik HJ1, Lee JE2.

Comparative analysis of BRCA1 and BRCA2 variants of uncertain significance in patients with breast cancer: a multifactorial probability-based model versus ACMG standards and guidelines for interpreting sequence variants

Park KS1¹, Cho EY2, Nam SJ3, Ki CS4, Kim JW4.

Assessment of pathologic response and long-term outcome in locally advanced breast cancers after neoadjuvant chemotherapy: comparison of pathologic classification systems

Choi M1¹, Park YH2, Ahn JS2, Im YH2, Nam SJ3, Cho SY4, Cho EY5.

Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society

Ryu JM1¹, Lee HJ2, Yoon TI3, Lee ES4, Lee SJ5, Jung JH6, Chae BJ7, Nam SJ1, Lee JE1, Lee SK1, Bae SY1, Yu J1, Kim SW8; Korean Breast Cancer Society Consortium.

Elevated IL-1 beta expression induces invasiveness of triple negative breast cancer cells and is suppressed by zerumbone

Jeon M1¹, Han J2, Nam SJ2, Lee JE3, Kim S4.

Body Mass Index with Tumor F-18-FDG Uptake Improves Risk Stratification in Patients with Breast Cancer

Hyun SH1¹, Ahn HK2, Lee JH1, Choi JY1, Kim BT1, Park YH3, Im YH3, Lee JE4, Nam SJ4, Lee KH1.

Clinicopathologic Features and Long-Term Outcomes of Elderly Breast Cancer Patients: Experiences at a Single Institution in Korea

Kim HK1¹, Ham JS1, Byeon S1, Yoo KH1, Jung KS1, Song HN1, Cho J1, Lee JY1, Lim SH1, Kim HS1, Kim JY1, Lee JE2, Kim SW2, Nam SJ2, Lee SK2, Bae SY2, Ahn JS1, Im YH1, Park YH1.

STC-1 expression is upregulated through an Akt/NF-B-dependent pathway in triple-negative breast cancer cells

Jeon M1¹, Han J1, Nam SJ1, Lee JE1, Kim S1.

Clinicopathological Features and Prognostic Factors Affecting Survival Outcomes in Isolated Locoregional Recurrence of Breast Cancer: Single-Institutional Series

Lee MY1¹, Chang WJ1, Kim HS1, Lee JY1, Lim SH1, Lee JE2, Kim SW2, Nam SJ2, Ahn JS1, Im YH1, Park YH1.

The relationship between nuclear factor (NF)-kappa B family gene expression and prognosis in triple-negative breast cancer (TNBC) patients receiving adjuvant doxorubicin treatment

Kim JY¹, Jung HH, Ahn S, Bae S, Lee SK, Kim SW, Lee JE, Nam SJ, Ahn JS, Im YH

Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-beta 2 expression

Kim S1¹, Han J2, Jeon M2,3, You D2,3, Lee J2, Kim HJ2, Bae S2, Nam SJ2, Lee JE4,5.

Feasibility of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Breast Cancer Patients with Tumor-Nipple Distance Less Than 2.0 cm

Ryu JM1¹, Nam SJ1, Kim SW1, Lee SK1, Bae SY1, Yi HW1, Park S1, Paik HJ1, Lee JE2.

Analysis of BRIP1 Variants among Korean Patients with BRCA1/2 Mutation-Negative High-Risk Breast Cancer

Kim H1¹, Cho DY2, Choi DH3, Jung GH2, Shin I2, Park W3, Huh SJ3, Nam SJ4, Lee JE4, Gil WH4, Kim SW4.

Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast Cancer Patients with 10 or More Axillary Nodes

Kim SW1¹, Choi DH2, Huh SJ2, Park W2, Nam SJ3, Kim SW3, Lee JE3, Im YH4, Ahn JS4, Park YH4.

Limited Supraclavicular Radiation Field in Breast Cancer With >= 10 Positive Axillary Lymph Nodes

Yu JI1¹, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.

Frequency of MED12 mutations in phyllodes tumors: Inverse correlation with histologic grade

Yoon N1¹, Bae GE2, Kang SY1, Choi MS1, Hwang HW1, Kim SW3, Lee JE3, Nam SJ3, Gong G4, Lee HJ4, Bae YK5, Lee A6, Cho EY1.

The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progress

Kim HA1¹, Ahn SH2, Nam SJ3, Park S4, Ro J5, Im SA6, Jung YS7, Yoon JH8, Hur MH9, Choi YJ10, Lee SJ11, Jeong J12, Cho SH13, Kim SY14, Lee MH15, Kim LS16, Moon BI17, Kim TH18, Park C19, Kim SJ20, Jung SH21, Park H22, Gwak GH23, Kang SH24, Kim JG25, Kim J26, Choi SY27, Lim CW28, Kim D29, Yoo Y30, Song YJ31, Kang YJ32, Jung SS33, Shin HJ34, Lee KJ35, Han SH7, Lee ES5, Han W36, Kim HJ2, Noh WC37.

MEK activity controls IL-8 expression in tamoxifen-resistant MCF-7 breast cancer cells

Kim S1¹, Jeon M1, Lee JE1, Nam SJ1.

Characterization of Korean Male Breast Cancer Using an Online Nationwide Breast-Cancer Database Matched-Pair Analysis of Patients With Female Breast Cancer

Choi MY1¹, Lee SK, Lee JE, Park HS, Lim ST, Jung Y, Ko BK, Nam SJ; Korean Breast Cancer Society.

MEK-dependent IL-8 induction regulates the invasiveness of triple-negative breast cancer cells

Kim S1¹, Lee J2, Jeon M2,3, Lee JE2,3, Nam SJ4.

Background Parenchymal Enhancement on Preoperative Magnetic Resonance Imaging Association With Recurrence-Free Survival in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

Choi JS1¹, Ko ES, Ko EY, Han BK, Nam SJ.

Prognostic value of ERBB4 expression in patients with triple negative breast cancer

Kim JY1¹, Jung HH2, Do IG3, Bae S4, Lee SK5, Kim SW6, Lee JE7, Nam SJ8, Ahn JS9, Park YH10,11, Im YH12,13.

Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-beta 1 signaling pathway

Kim S1¹, Lee J1, Jeon M1,2, Lee JE1,2, Nam SJ1.

Assessment of Invasive Breast Cancer Heterogeneity Using Whole-Tumor Magnetic Resonance Imaging Texture Analysis Correlations With Detailed Pathological Findings

Ko ES1¹, Kim JH, Lim Y, Han BK, Cho EY, Nam SJ.

Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer

Lee JY1¹, Park K2, Lim SH1, Kim HS1, Yoo KH1, Jung KS1, Song HN1, Hong M3, Do IG3, Ahn T2, Lee SK4, Bae SY4, Kim SW4, Lee JE4, Nam SJ4, Kim DH5, Jung HH6, Kim JY1, Ahn JS1, Im YH1, Park YH1.

Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard Treatments

Yu JI1¹, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.

Patient-reported assessment of self-management strategies of health in cancer patients: development and validation of the Smart Management Strategy for Health Assessment Tool (SAT)

Yun YH1¹,2, Jung JY1, Sim JA1, Choi H1, Lee JM3, Noh DY2,4, Han W2,4, Park KJ4, Jeong SY4, Park JW4, Wu HG5, Chie EK5, Kim HJ5, Lee JH6, Zo ZI7, Kim S8, Lee JE8, Nam SJ8, Lee ES3, Oh JH3, Kim YW3, Kim YT2,9, Shim YM7.

Initial Experience with a Wireless Ultrasound-Guided Vacuum-Assisted Breast Biopsy Device

Choi ER1¹, Han BK1, Ko ES1, Ko EY1, Choi JS1, Cho EY2, Nam SJ3.

Independent Prognostic Factors for Overall Survival after Salvage Operation for Ipsilateral Breast Tumor Recurrence Following Breast-Conserving Surgery

Lee JH1¹, Lee SK1, Park SM1, Ryu JM1, Paik HJ1, Yi HW1, Bae SY1, Lee JE1, Kim SW1, Nam SJ1.

The Value of Ki67 in Very Young Women with Hormone Receptor-Positive Breast Cancer: Retrospective Analysis of 9,321 Korean Women

Kim J1¹, Han W2, Jung SY3, Park YH4, Moon HG5, Ahn SK6, Lee JW7, Kim MK5, Kim JJ5, Lee ES5, You TK1, Kang HS3, Lee ES3, Ro J3, Lee JE4, Nam SJ4, Yim YH4, Park IA5, Noh DY5.

Impact on Survival of Regular Postoperative Surveillance for Patients with Early Breast Cancer

Lee JY1¹, Lim SH1, Lee MY1, Kim H1, Kim M1, Kim S1, Jung HA1, Sohn I2, Gil WH3, Lee JE3, Kim SW3, Nam SJ3, Ahn JS1, Im YH1, Park YH1.

Incidental Findings on Simulation CT Images for Adjuvant Radiotherapy in Breast Cancer Patients

Park JS1¹, Choi DH2, Huh SJ1, Park W1, Nam SJ3, Lee JE3, Kil WH3, Lee KS4.

Prognostic Significance of a Complete Response on Breast MRI in Patients Who Received Neoadjuvant Chemotherapy According to the Molecular Subtype

Ko ES1¹, Han H2, Han BK1, Kim SM3, Kim RB4, Lee GW5, Park YH6, Nam SJ7.

Molecular characterization of patients with pathologic complete response or early failure after neoadjuvant chemotherapy for locally advanced breast cancer using next generation sequencing and nCounter assay

Park K1¹, Choi MK2, Jung HH3, Do IG4, Lee KH5, Ahn T1, Kil WH6, Kim SW6, Lee JE6, Nam SJ6, Kim DH7, Ahn JS2, Im YH2,3, Park YH2,3.

Comparison of Clinicopathological Features and Treatment Results between Invasive Lobular Carcinoma and Ductal Carcinoma of the Breast

Park JS1¹, Choi DH1, Huh SJ1, Park W1, Kim YI2, Nam SJ3, Lee JE3, Kil WH3.

Heterozygous germline mutations in NBS1 among Korean patients with high-risk breast cancer negative for BRCA1/2 mutation

Kim H1¹, Cho DY, Choi DH, Jung GH, Shin I, Park W, Huh SJ, Kim SW, Park SK, Lee JW, Nam SJ, Lee JE, Gil WH, Kim SW.

Mammographic density and risk of breast cancer in Korean women

Elevated TGF-beta 1 and -beta 2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells

Differential effect of EGFR inhibitors on tamoxifen-resistant breast cancer cells

Kim S1¹, Lee J1, Oh SJ1, Nam SJ1, Lee JE1.

Quantitative changes in skin composition parameters due to chemotherapy in breast cancer patients: a cohort study

Kang D1¹, Kim IR, Im YH, Park YH, Ahn JS, Lee JE, Nam SJ, Park H, Kim E, Lee HK, Lee DY, Cho J.

Distinguishing Low-Risk Luminal A Breast Cancer Subtypes with Ki-67 and p53 Is More Predictive of Long-Term Survival

Lee SK1¹, Bae SY1, Lee JH1, Lee HC1, Yi H1, Kil WH1, Lee JE1, Kim SW1, Nam SJ1.

Prevalence and clinical outcomes of young breast cancer (YBC) patients according to intrinsic breast cancer subtypes: Single institutional experience in Korea

Park YH1¹, Lee SJ1, Jung HA1, Kim SM1, Kim MJ1, Kil WH2, Lee JE2, Nam SJ2, Ahn JS1, Im YH3.

Preoperative Magnetic Resonance Imaging-Based Breast Volumetry for Immediate Breast Reconstruction

Kim H1¹, Mun GH, Wiraatmadja ES, Lim SY, Pyon JK, Oh KS, Lee JE, Nam SJ, Bang SI.

The Basic Facts of Korean Breast Cancer in 2012: Results from a Nationwide Survey and Breast Cancer Registry Database

Kim Z1¹, Min SY2, Yoon CS3, Jung KW4, Ko BS5, Kang E6, Nam SJ7, Lee S8, Hur MH3; Korean Breast Cancer Society.

Immediate Postoperative Inflammation Is an Important Prognostic Factor in Breast Cancer

Lee SK1¹, Choi MY, Bae SY, Lee JH, Lee HC, Kil WH, Lee JE, Kim SW, Nam SJ.

Is Holm Zone III safe from fat necrosis in medial row perforator-based deep inferior epigastric perforator flaps

Lee KT1¹, Lee JE2, Nam SJ2, Han BK3, Mun GH1.

Volume-based Metabolic Tumor Response to Neoadjuvant Chemotherapy Is Associated with an Increased Risk of Recurrence in Breast Cancer

Hyun SH1¹, Ahn HK, Park YH, Im YH, Kil WH, Lee JE, Nam SJ, Cho EY, Choi JY.

Induction of fibronectin by HER2 overexpression triggers adhesion and invasion of breast cancer cells

Jeon M1¹, Lee J2, Nam SJ2, Shin I3, Lee JE4, Kim S5.

A seven-gene signature can predict distant recurrence in patients with triple- negative breast cancers who receive adjuvant chemotherapy following surgery

Park YH1¹, Jung HH, Do IG, Cho EY, Sohn I, Jung SH, Kil WH, Kim SW, Lee JE, Nam SJ, Ahn JS, Im YH.

Surgery of primary tumour has survival benefit in metastatic breast cancer with single-organ metastasis, especially bone

Rhu J¹, Lee SK, Kil WH, Lee JE, Nam SJ.

Lateral neck sentinel lymph node biopsy in papillary thyroid carcinoma, is it really necessary A randomized, controlled study

Lee SK1¹, Lee JH1, Bae SY1, Kim J1, Kim M1, Lee HC1, Jung YY2, Kil WH1, Kim SW1, Lee JE1, Nam SJ1, Choe JH1, Kim JH1, Kim JS3.

Survival Improvement in Korean Breast Cancer Patients Due to Increases in Early-Stage Cancers and Hormone Receptor Positive/HER2 Negative Subtypes: A Nationwide Registry-Based Study

You JM1¹, Kim YG2, Moon HG2, Nam SJ3, Lee JW4, Lim W5, Lee MR6, Noh DY2, Han W2.

Sentinel Lymph Node Biopsy Alone after Neoadjuvant Chemotherapy in Patients with Initial Cytology-Proven Axillary Node Metastasis

Kim JY1¹, Kim MK2, Lee JE3, Jung Y1, Bae SY3, Lee SK3, Kil WH3, Kim SW3, Kim KS4, Nam SJ3, Han S1.

Poor prognosis of single hormone receptor-positive breast cancer: similar outcome as triple-negative breast cancer

Bae SY1¹, Kim S2, Lee JH3, Lee HC4, Lee SK5, Kil WH6, Kim SW7, Lee JE8, Nam SJ9.

Proportion and Clinical Outcomes of Postoperative Radiotherapy Omission after Breast-Conserving Surgery in Women with Breast Cancer

Yu JI1¹, Choi DH1, Huh SJ1, Park W1, Nam SJ2, Kim SW2, Lee JE2, Kil WH2, Im YH3, Ahn JS3, Park YH3.

Effect of menstrual cycle and menopausal status on apparent diffusion coefficient values and detectability of invasive ductal carcinoma on diffusion-weighted MRI

Shin S1¹, Ko ES, Kim RB, Han BK, Nam SJ, Shin JH, Hahn SY.

Prognostic relevance of biological subtype overrides that of TNM staging in breast cancer: discordance between stage and biology

Jung HA1¹, Park YH, Kim M, Kim S, Chang WJ, Choi MK, Hong JY, Kim SW, Kil WH, Lee JE, Nam SJ, Ahn JS, Im YH.

Effect of Antiadhesion Barrier Solution and Fibrin on Capsular Formation After Silicone Implant Insertion in a White Rat Model

Lee SG1¹, Lee SD, Kim MK, Ryu WS, Jung SP, Kim S, Kim HY, Yoon ES, Kim CH, Nam SJ, Bae JW.

Zerumbone suppresses EGF-induced CD44 expression through the inhibition of STAT3 in breast cancer cells

Kim S1¹, Kil WH1, Lee J1, Oh SJ1, Han J1, Jeon M1, Jung T1, Lee SK1, Bae SY1, Lee HC1, Lee JH1, Yi HW1, Kim SW1, Nam SJ1, Lee JE1.

Invasive Paget disease of the breast: 20 years of experience at a single institution

Lee HW1¹, Kim TE1, Cho SY1, Kim SW2, Kil WH2, Lee JE2, Nam SJ2, Cho EY3.

Association between Socioeconomic Status and Altered Appearance Distress, Body Image, and Quality of Life Among Breast Cancer Patients

Chang O1¹, Choi EK, Kim IR, Nam SJ, Lee JE, Lee SK, Im YH, Park YH, Cho J.

Zerumbone Suppresses IL-1 beta-induced Cell Migration and Invasion by Inhibiting IL-8 and MMP-3 Expression in Human Triple-negative Breast Cancer Cells

Han J1¹, Bae SY, Oh SJ, Lee J, Lee JH, Lee HC, Lee SK, Kil WH, Kim SW, Nam SJ, Kim S, Lee JE.

Induction of fibronectin in response to epidermal growth factor is suppressed by silibinin through the inhibition of STAT3 in triple negative breast cancer cells

Kim S1¹, Jeon M1, Lee J1, Han J1, Oh SJ1, Jung T1, Nam SJ1, Kil WH1, Lee JE1.

Excision alone for small size ductal carcinoma in situ of the breast

Kim H1¹, Noh JM2, Choi DH3, Lee J4, Nam SJ5, Lee JE5, Park W4, Huh SJ4.

Anticancer effect of silibinin on the xenograft model using MDA-MB-468 breast cancer cells

Kil WH1¹, Kim SM1, Lee JE1, Park KS2, Nam SJ1.

Ovarian function preservation with GnRH agonist in young breast cancer patients: Does it impede the effect of adjuvant chemotherapy

Kim J1¹, Kim M2, Lee JH2, Lee H2, Lee SK2, Bae SY2, Jun SY3, Kil WH2, Lee JE4, Kim SW2, Nam SJ2.

Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients

Choi EK1¹, Kim IR, Chang O, Kang D, Nam SJ, Lee JE, Lee SK, Im YH, Park YH, Yang JH, Cho J.

Clinical Significance of the Axillary Arch in Sentinel Lymph Node Biopsy

Kil WH1¹, Lee JE1, Nam SJ1.

Clinicopathological features of early failure of neoadjuvant chemotherapy in locally advanced breast cancer

Choi MK1¹, Park YH, Kil WH, Lee JE, Nam SJ, Ahn JS, Im YH.

Breast Cancer Screening Knowledge and Perceived Health Beliefs among Immigrant Women in Korea

Kim J1¹, Lee SK2, Lee J3, Choi MY3, Jung SP4, Kim MK2, Kim S2, Nam SJ2, Lee JE2, Kil WH2.

Role of secreted type I collagen derived from stromal cells in two breast cancer cell lines

Kim SH1¹, Lee HY2, Jung SP2, Kim S3, Lee JE3, Nam SJ3, Bae JW2.

Validation and Comparison of CS-IHC4 Scores with a Nomogram to Predict Recurrence in Hormone Receptor-Positive Breast Cancers

Park YH1¹, Im SA, Cho EY, Ahn JH, Woo SY, Kim S, Keam B, Lee JE, Han W, Nam SJ, Park IA, Noh DY, Yang JH, Ahn JS, Im YH.

Aberrant DNA methylation of integrin alpha 4 in human breast cancer

Do SI1¹, Ko E, Kang SY, Lee JE, Nam SJ, Cho EY, Kim DH.

The Protective Effect of Parity in Hormone Receptor-Positive, Ki-67 Expressing Breast Cancer

Lee SK1¹, Kim SW, Han SA, Kil WH, Lee JE, Nam SJ.

Comparison of acute skin reaction following morning versus late afternoon radiotherapy in patients with breast cancer who have undergone curative surgical resection

Noh JM1¹, Choi DH, Park H, Huh SJ, Park W, Seol SW, Jeong BK, Nam SJ, Lee JE, Kil WH.

Apparent Diffusion Coefficient in Estrogen Receptor-Positive Invasive Ductal Breast Carcinoma: Correlations with Tumor-Stroma Ratio

Ko ES1¹, Han BK, Kim RB, Cho EY, Ahn S, Nam SJ, Ko EY, Shin JH, Hahn SY.

Genetic anticipation of familial breast cancer with or without BRCA mutation in the Korean population

Noh JM1¹, Choi DH2, Baek H3, Kim MJ4, Park H1, Huh SJ1, Park W1, Nam SJ5, Lee JE5, Kil WH5, Haffty BG6.

Effect of Axillary Lymph Node Dissection after Sentinel Lymph Node Biopsy on Overall Survival in Patients with T1 or T2 Node-positive Breast Cancer: Report from the Korean Breast Cancer Society

Park HS1¹, Chae BJ, Song BJ, Jung SS, Han W, Nam SJ, Youn HJ, Ko BK, Kim DW; Korea Breast Cancer Society.

Protein kinase C- a downregulates estrogen receptor- a by suppressing c- Jun phosphorylation in estrogen receptor- positive breast cancer cells

Kim S1¹, Lee J1, Lee SK1, Bae SY1, Kim J1, Kim M1, Kil WH1, Kim SW1, Lee JE1, Nam SJ1.

Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)

Kim J¹, Lim W, Kim EK, Kim MK, Paik NS, Jeong SS, Yoon JH, Park CH, Ahn SH, Kim LS, Han S, Nam SJ, Kang HS, Kim SI, Yoo YB, Jeong J, Kim TH, Kang T, Kim SW, Jung Y, Lee JE, Kim KS, Yu JH, Chae BJ, Jung SY, Kang E, Choi SY, Moon HG, Noh DY, Han W1.

Polyostotic Fibrous Dysplasia Mimicking Multiple Bone Metastases in a Patient with Ductal Carcinoma In Situ

Lee JH1¹, Kim SY2, Lee JE1, Cho EY3, Choi YL3, Choi JY4, Han SW2, Kim SW1, Kil WH1, Nam SJ1.

Development and validation of Chemotherapy-induced Alopecia Distress Scale (CADS) for breast cancer patients

Cho J1¹, Choi EK, Kim IR, Im YH, Park YH, Lee S, Lee JE, Yang JH, Nam SJ.

Primary Follicular Lymphoma in a Male Breast: A Case Report

Jung SP1¹, Han KM2, Kim SJ3, Nam SJ4, Bae JW1, Lee JE4.

Acute skin toxicity in Korean breast cancer patients carrying BRCA mutations

Park H1¹, Choi DH, Noh JM, Huh SJ, Park W, Nam SJ, Lee JE.

Tubular Carcinoma of the Breast: Clinicopathologic Features and Survival Outcome Compared with Ductal Carcinoma In Situ

Min Y1¹, Bae SY1, Lee HC1, Lee JH1, Kim M1, Kim J1, Lee SK1, Kil WH1, Kim SW1, Lee JE1, Nam SJ1.

Berberine Suppresses TPA-Induced Fibronectin Expression through the Inhibition of VEGF Secretion in Breast Cancer Cells

Kim S1¹, Oh SJ, Lee J, Han J, Jeon M, Jung T, Lee SK, Bae SY, Kim J, Gil WH, Kim SW, Lee JE, Nam SJ.

Nomogram for predicting invasion in patients with a preoperative diagnosis of ductal carcinoma in situ of the breast

Lee SK1¹, Yang JH, Woo SY, Lee JE, Nam SJ.

Aromatase inhibitor-associated musculoskeletal symptoms: incidence and associated factors

Park JY1¹, Lee SK, Bae SY, Kim J, Kim MK, Kil WH, Lee JE, Nam SJ.

The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study

Han SA1¹, Kim SW, Kang E, Park SK, Ahn SH, Lee MH, Nam SJ, Han W, Bae YT, Kim HA, Cho YU, Chang MC, Paik NS, Hwang KT, Kim SJ, Noh DY, Choi DH, Noh WC, Kim LS, Kim KS, Suh YJ, Lee JE, Jung Y, Moon BI, Yang JH, Son BH, Yom CK, Kim SY, Lee H, Jung SH; KOHBRA Research Group and the Korean Breast Cancer Society.

The Role of the CDH1 Promoter Hypermethylation in the Axillary Lymph Node Metastasis and Prognosis

Jung SP1¹, Kim S, Nam SJ, Kim I, Bae JW.

Nationwide Survey of Use of Vacuum-assisted Breast Biopsy in South Korea

Park HL1¹, Min SY, Kwon SH, Song JY, Shin H, Nam SJ, Yang JH; KOREAN BREAST CANCER SOCIETY MEMBERS.

The Clinical Meaning of Intramammary Lymph Nodes

Occult Breast Cancers Manifesting as Axillary Lymph Node Metastasis in Men: A Two-Case Report

Hur SM1¹, Cho DH, Lee SK, Choi MY, Bae SY, Koo MY, Kim S, Nam SJ, Lee JE, Yang JH.

Adjuvant Chemotherapy and Survival of Elderly Korean Patients with Breast Carcinoma

Jung SP1¹, Lee JE, Lee SK, Kim S, Choi MY, Bae SY, Kim J, Kil WH, Choe JH, Kim JH, Kim JS, Nam SJ.

A functional comparison between the HER2(high)/HER3 and the HER2l(ow/)HER3 dimers on heregulin-beta 1-induced MMP-1 and MMP-9 expression in breast cancer cells

Kim S1¹, Han J, Shin I, Kil WH, Lee JE, Nam SJ.

Lymph Node Metastasis in Patients with Frozen Section Analyses That Are Negative for Tumors

Lee SK1¹, Lee KW, Kim S, Choi MY, Kim J, Lee J, Jung SP, Choe JH, Kim JH, Kim JS, Lee JE, Yang JH, Nam SJ.

Berberine Suppresses the TPA-Induced MMP-1 and MMP-9 Expressions Through the Inhibition of PKC-alpha in Breast Cancer Cells

Kim S1¹, Han J, Lee SK, Choi MY, Kim J, Lee J, Jung SP, Kim JS, Kim JH, Choe JH, Lee JE, Nam SJ.

Perception, Attitudes, Preparedness and Experience of Chemotherapy-Induced Alopecia among Breast Cancer Patients: a Qualitative Study

Kim IR1¹, Cho J, Choi EK, Kwon IG, Sung YH, Lee JE, Nam SJ, Yang JH.

A prognostic model for lymph node-negative breast cancer patients based on the integration of proliferation and immunity

Oh E1¹, Choi YL, Park T, Lee S, Nam SJ, Shin YK.

Spectra of BRCA1 and BRCA2 mutations in Korean patients with breast cancer: the importance of whole-gene sequencing

Jang JH1¹, Lee JE, Kwon MJ, Ki CS, Kim JW, Nam SJ, Yang JH.

Long-Term Outcome of Internal Mammary Lymph Node Detected by Lymphoscintigraphy in Early Breast Cancer

Koo MY1¹, Lee SK, Bae SY, Choi MY, Cho DH, Kim S, Lee JE, Nam SJ, Yang JH.

Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study

Kang E1¹, Yang EJ, Kim SM, Chung IY, Han SA, Ku DH, Nam SJ, Yang JH, Kim SW.

Smad7 acts as a negative regulator of the epidermal growth factor (EGF) signaling pathway in breast cancer cells

Kim S1¹, Han J, Lee SK, Koo M, Cho DH, Bae SY, Choi MY, Kim JS, Kim JH, Choe JH, Yang JH, Nam SJ, Lee JE.

MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7

Kim SJ1¹, Shin JY, Lee KD, Bae YK, Sung KW, Nam SJ, Chun KH.

Silibinin Suppresses EGFR Ligand-induced CD44 Expression through Inhibition of EGFR Activity in Breast Cancer Cells

Kim S1¹, Han J, Kim JS, Kim JH, Choe JH, Yang JH, Nam SJ, Lee JE.

Invited Commentary on: Can CD44+/CD24-Tumor Stem Cells Be Used to Determine the Extent of Breast Cancer Invasion Following Neoadjuvant Chemotherapy

Lee JE1¹, Nam SJ.

Commentary on: Incidental Breast Cancers Identified in a One-Stop Symptomatic Breast Clinic

Lee JE1¹, Yang JH, Nam SJ.

Survey of Psychosocial Problems Facing Breast Cancer Survivors after Undergoing a Mastectomy and Their Awareness of Breast Reconstruction

Development of microRNA-145 for therapeutic application in breast cancer

Kim SJ1¹, Oh JS, Shin JY, Lee KD, Sung KW, Nam SJ, Chun KH.

12-O-Tetradecanoyl phorbol-13-acetate (TPA)-induced growth arrest is increased by silibinin by the down-regulation of cyclin B1 and cdc2 and the up-regulation of p21 expression in MDA-MB231 human breast cancer cells

Kim S1¹, Lee HS, Lee SK, Kim SH, Hur SM, Kim JS, Kim JH, Choe JH, Shin I, Yang JH, Lee JE, Nam SJ.

The Change of Practice Patterns of the Hereditary Breast Cancer Management in Korea after the Korean Hereditary Breast Cancer Study

Cystatin M loss is associated with the losses of estrogen receptor, progesterone receptor, and HER4 in invasive breast cancer

Ko E1¹, Park SE, Cho EY, Kim Y, Hwang JA, Lee YS, Nam SJ, Bang S, Park J, Kim DH.

The Role of PET CT to Evaluate the Response to Neoadjuvant Chemotherapy in Advanced Breast Cancer: Comparison With Ultrasonography and Magnetic Resonance Imaging

Choi JH1¹, Lim HI, Lee SK, Kim WW, Kim SM, Cho E, Ko EY, Han BK, Park YH, Ahn JS, Im YH, Lee JE, Yang JH, Nam SJ.

Secondary Partial Mastectomy with Contralateral Sentinel Lymph Node Biopsy for Ipsilateral Breast Cancer Recurrence after Conservative Surgery: Report of 2 Cases

The association of carbohydrate intake, glycemic load, glycemic index, and selected rice foods with breast cancer risk: a case-control study in South Korea

Yun SH1¹, Kim K, Nam SJ, Kong G, Kim MK.

Dietary Intake of Nitrate Relative to Antioxidant Vitamin in Relation to Breast Cancer Risk: A Case-Control Study

Yang YJ1¹, Hwang SH, Kim HJ, Nam SJ, Kong G, Kim MK.

Intracystic Papillary Carcinoma in the Male Breast

Biopsychosocial Predictors of the Quality of Life in Breast Cancer Patients

A case-control study on seaweed consumption and the risk of breast cancer

Yang YJ1¹, Nam SJ, Kong G, Kim MK.

Characteristics of Metastasis in the Breast From Extramammary Malignancies

Lee SK1¹, Kim WW, Kim SH, Hur SM, Kim S, Choi JH, Cho EY, Han SY, Hahn BK, Choe JH, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH.

Association of shared decision-making with type of breast cancer surgery: a cross-sectional study

Lee MK1¹, Noh DY, Nam SJ, Ahn SH, Park BW, Lee ES, Yun YH.

Does pre-operative breast magnetic resonance imaging in addition to mammography and breast ultrasonography change the operative management of breast carcinoma

Lim HI1¹, Choi JH, Yang JH, Han BK, Lee JE, Lee SK, Kim WW, Kim S, Kim JS, Kim JH, Choe JH, Cho EY, Kang SS, Shin JH, Ko EY, Kim SW, Nam SJ.

Implications of Isolated Tumor Cells in Sentinel Lymph Nodes of Breast Cancer Patients

Arm Sentinel Lymph Node Detection for Preserving the Arm Lymphatic System

Correlates of existential well-being and their association with health-related quality of life in breast cancer survivors compared with the general population

Shin HW1¹, Noh DY, Lee ES, Nam SJ, Park BW, Ahn SH, Yun YH.

Screening and Diagnosis for Breast Cancers

Commentary on "The Number of Removed Lymph Nodes for an Acceptable False Negative Rate in Sentinel Node Biopsy for Breast Cancer"

Impact of breast cancer diagnosis and treatment on work-related life and factors affecting them

Ahn E1¹, Cho J, Shin DW, Park BW, Ahn SH, Noh DY, Nam SJ, Lee ES, Yun YH.

Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells

Kim S1¹, Choi JH, Lim HI, Lee SK, Kim WW, Kim JS, Kim JH, Choe JH, Yang JH, Nam SJ, Lee JE.

The Breast and Ovarian Cancer Risks in Korea Due to Inherited Mutations in BRCA1 and BRCA2: A Preliminary Report

Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers

Woo HM1¹, Kim KM, Choi MH, Jung BH, Lee J, Kong G, Nam SJ, Kim S, Bai SW, Chung BC.

Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients

Choi YJ1¹, Choi YL, Cho EY, Shin YK, Sung KW, Hwang YK, Lee SJ, Kong G, Lee JE, Kim JS, Kim JH, Yang JH, Nam SJ.

The Impact of the Ratio of Positive Nodes to Removed Nodes on Recurrence and Overall Survival in Node Positive Breast Cancer Patients

Martin FT1¹, O'Fearraigh C, Hanley C, Curran C, Sweeney KJ, Kerin MJ.

Dietary Intake of Soy Protein and Tofu in Association With Breast Cancer Risk Based on a Case-Control Study

Kim MK1¹, Kim JH, Nam SJ, Ryu S, Kong G.

Intraoperative identification of suspicious palpable lymph nodes as an integral part of sentinel node biopsy in patients with breast cancer

Choi YJ1¹, Kim JH, Nam SJ, Ko YH, Yang JH.

Association of clinical experiences with patient-reported outcomes among breast cancer surgery patients: breast cancer quality care study

Noh DY1¹, Nam SJ, Ahn SH, Park BW, Lee ES, Lee MK, Kim SH, Kim YM, Park SM, Yun YH.

A case-control study on the dietary intake of mushrooms and breast cancer risk among Korean women

Hong SA1¹, Kim K, Nam SJ, Kong G, Kim MK.

Trends in breast cancer treatment in Korea and impact of compliance with consensus recommendations on survival

Yun YH1¹, Park SM, Noh DY, Nam SJ, Ahn SH, Park BW, Lee ES.

Overexpression of interleukin-10 in sentinel lymph node with breast cancer

Woo SU1¹, Bae JW, Yang JH, Kim JH, Nam SJ, Shin YK.

Neuronal apoptosis inhibitory protein is overexpressed in patients with unfavorable prognostic factors in breast cancer

Choi J1¹, Hwang YK, Choi YJ, Yoo KE, Kim JH, Nam SJ, Yang JH, Lee SJ, Yoo KH, Sung KW, Koo HH, Im YH.

Analysis of prognostic factors and treatment modality changes in breast cancer: A single institution study in Korea

Lee WS1¹, Lee JE, Kim JH, Nam SJ, Yang JH.

Methylene blue for localization of sentinel lymph nodes in breast cancer: A comparison with isosulfan blue

Health-related quality of life in disease-free survivors of breast cancer with the general population

Ahn SH1¹, Park BW, Noh DY, Nam SJ, Lee ES, Lee MK, Kim SH, Lee KM, Park SM, Yun YH.

Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry in breast cancer

Choi YJ1¹, Yun HR, Yoo KE, Kim JH, Nam SJ, Choi YL, Ko YH, Kim BT, Yang JH.

Erlotinib prevents pulmonary metastasis in curatively resected breast carcinoma using a mouse model

Choi YJ1¹, Nam SJ, Son MJ, Kim DK, Kim JH, Yang JH, Kim MH, Song HS, Nam DH, Bang SI.

Hepatocellular carcinoma with metastasis to the breast

Immunoexpression of HBME-1, high molecular weight cytokeratin, cytokeratin 19, thyroid transcription factor-1, and E-cadherin in thyroid carcinomas

Choi YL1¹, Kim MK, Suh JW, Han J, Kim JH, Yang JH, Nam SJ.

Effect of core-needle biopsy vs fine-needle aspiration on pathologic measurement of tumor size in breast cancer

Yang JH1¹, Lee WS, Kim SW, Woo SU, Kim JH, Nam SJ.

Genetic polymorphism of CYP17 and breast cancer risk in Korean women

Shin MH1¹, Lee KM, Yang JH, Nam SJ, Kim JW, Yoo KY, Park SK, Noh DY, Ahn SH, Kim B, Kang D.

E-cadherin and cytokeratin subtype profiling in effusion cytology

Han J1¹, Kim MK, Nam SJ, Yang JH.

Comparison of intraoperative frozen section analysis of sentinel node with preoperative positron emission tomography in the diagnosis of axillary lymph node status in breast cancer patients

Yang JH1¹, Nam SJ, Lee TS, Lee HK, Jung SH, Kim BT.